|
|
|
| Webinar: Development Strategies for Platform Devices | Navigating Regulatory Complexities: Formulation, Compliance, and Market Approval This webinar focuses on FDA regulations for platform technologies in drug-device combinations, like prefilled syringes and autoinjectors. It covers strategies for bridging formulation changes, leveraging existing data for submissions, and de-risking innovation. Key takeaways include optimizing regulatory strategies, ensuring compliance, and balancing speed-to-market with FDA expectations for successful approval. Click here to learn more. |
|
|
|
|
| Compliance Considerations For Emergency-Use Delivery Systems | Article | By Richard Motruk and Nathan Blazei, Kymanox Corporation | Because auto-injectors are typically the delivery device of choice for emergency medications, see how they come with increased scrutiny from regulatory bodies regarding their safety and effectiveness. |
|
|
|
| Digital Maturity: A Roundtable Discussion | Video | IDBS UK HQ | Join our experts as they highlight the varied levels of digital maturity within companies and the importance of aligning digital initiatives with company objectives. |
|
|
| Treating Deficiencies In Employee Training And Mentorship | Article | By Jenny Minigh, inSeption Group | Investing in employee training and development is not just beneficial for the employees. Find out how it also contributes significantly to the organization’s success and competitive advantage. |
|
|
|
| Critical Cleaning For 3D Printing In The Life Sciences | White Paper | By Jeff Phillips, Alconox Inc. | Gain insight into the critical cleaning of hard surfaces utilized in 3D printing processes across industries, such as extruded plastics, photosensitive substrates, metals, and metal alloys. |
|
|
|
| The Buyer's Guide To Oligonucleotide Synthesis | e-book | Asahi Kasei Bioprocess | Uncover how to produce oligonucleotides at scale with this buyer's guide and the essential equipment, key features, and vendor considerations for successful oligonucleotide synthesis. |
|
|
|
|
|
|
|
|
|
|
By Nasim Pourarian and Kamran Zamanian, Ph.D. | GLP-1 receptor agonists (GLP-1RAs) are widely used in the treatment of type 2 diabetes. Examine the overview and market research on GLP-1 drugs, which includes the anticipated growth of the market and the current leaders in the space. | |
|
|
|
|
|
|
|
|
|
Connect With Pharmaceutical Online: |
|
|
|